Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance

Immune checkpoint blockades (ICBs) have revolutionized cancer treatment. Recent studies have revealed a subset of triple-negative breast cancer (TNBC) to be considered as an immunogenic breast cancer subtype. Characteristics of TNBC, such as higher mutation rates and number of tumor-infiltrating imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyungjoo, Choi, Je-Min, Lee, Kyung-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138553/
https://www.ncbi.nlm.nih.gov/pubmed/35625867
http://dx.doi.org/10.3390/biomedicines10051130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138553/
https://www.ncbi.nlm.nih.gov/pubmed/35625867
http://dx.doi.org/10.3390/biomedicines10051130

Ejemplares similares